Clinical trial
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate…
NCT00118742 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00118742 |
|---|---|
| Title | Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant |
| Official title | A Randomized, Open-label Study of the Effect of a Long-term Calcineurin Inhibitor-free Maintenance Regimen With CellCept and Sirolimus on Preservation of Renal Function and Prevention of Acute Rejection in Recipients of an Orthotropic Liver Transplant |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil [CellCept], Tacrolimus, Cyclosporine, Sirolimus |
| Enrollment | 293 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 12, 2005 |
| Last update posted | Aug 3, 2010 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: